An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent ΔE1-E2-E3-E4 Ad5 vectors

被引:21
|
作者
Catalucci, D [1 ]
Sporeno, E [1 ]
Cirillo, A [1 ]
Ciliberto, G [1 ]
Nicosia, A [1 ]
Colloca, S [1 ]
机构
[1] Ist Ric Biol Mol P Angeletti, I-00040 Pomezia, Roma, Italy
关键词
D O I
10.1128/JVI.79.10.6400-6409.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Production of multiply deleted adenoviral (Ad) vectors with increased cloning capacity and reduced immunogenicity to adenovirus gene products requires the concomitant generation of efficient packaging cell lines. High expression levels of the complementing genes must be achieved in a coordinated fashion with viral replication. This is a particularly difficult task in light of the significant cytotoxicity displayed by adenoviral proteins. To this end, we developed a novel adenovirus-based amplicon with an Epstein-Barr virus origin of replication, Ad type 5 (Ad5) inverted terminal repeats, all Ad5 early region 2 (E2) genes, and the early region 4 (E4) open reading frame 6 (ORF6) under the control of a tetracycline-dependent promoter. The amplicon (pE2) was stably maintained in multiple copies in the nuclei of 293 cells stably expressing the Epstein-Barr virus nuclear antigen 1 (EBNA1) and allowed replication as a linear DNA upon induction of E2 and ORF6 gene expression. A stable cell line (M) was generated by introducing pE2 into 293EBNATet cells expressing the tetracycline-dependent transcriptional silencer and the reverse Tet transactivator (rtTA2). Upon induction with doxicycline, 2E2 cells produced higher levels of polymerase, precursor terminal protein (pTP), and DNA binding protein than noninduced 2E2 cells infected with first-generation Ad5 vector and supported efficient amplification of a multiply deleted Ad5 vector lacking E1, E2, E3, and E4 genes (Ad5 Delta E1-4). The high cloning capacity of Ad5 Delta E1-4 (up to 12.6 kb) was exploited to construct a vector encoding the entire hepatitis C virus (HCV) polyprotein. Infection of HeLa cells by the resulting vector showed high levels of correctly processed HCV proteins.
引用
收藏
页码:6400 / 6409
页数:10
相关论文
共 50 条
  • [1] Induction and comparison of SIV immunity in Ad5 naive and Ad5 immune non-human primates using an Ad5 [El-, E2b-] based vaccine
    Gabitzsch, Elizabeth S.
    Xu, Younong
    Balint, Joseph P., Jr.
    Balcaitis, Stephanie
    Sanders-Beer, Brigitte
    Jones, Frank R.
    VACCINE, 2011, 29 (45) : 8101 - 8107
  • [2] EFFICIENT NUCLEAR-LOCALIZATION AND IMMORTALIZING ABILITY, 2 FUNCTIONS DEPENDENT ON THE ADENOVIRUS-TYPE-5 (AD5) E1A 2ND EXON, ARE NECESSARY FOR COTRANSFORMATION WITH AD5 E1B BUT NOT WITH T24RAS
    DOUGLAS, JL
    QUINLAN, MP
    JOURNAL OF VIROLOGY, 1995, 69 (12) : 8061 - 8065
  • [3] The Ad5 [E1-, E2b-]-based Vector: A New and Versatile Gene Delivery Platform
    Jones, Frank R.
    Gabitzsch, Elizabeth S.
    Balint, Joseph P., Jr.
    ADVANCES IN GLOBAL HEALTH THROUGH SENSING TECHNOLOGIES 2015, 2015, 9490
  • [4] An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice
    E S Gabitzsch
    Y Xu
    S Balcaitis
    J P Balint
    F R Jones
    Cancer Gene Therapy, 2011, 18 : 326 - 335
  • [5] An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice
    Gabitzsch, E. S.
    Xu, Y.
    Balcaitis, S.
    Balint, J. P., Jr.
    Jones, F. R.
    CANCER GENE THERAPY, 2011, 18 (05) : 326 - 335
  • [6] An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences
    Xu, ZZ
    Nevels, M
    MacAvoy, ES
    Lockett, LJ
    Curiel, D
    Dobner, T
    Both, GW
    VIROLOGY, 2000, 270 (01) : 162 - 172
  • [7] Effects of the Ad5 upstream E1 region and gene products on heterologous promoters
    Hoffmann, D
    Jogler, C
    Wildner, O
    JOURNAL OF GENE MEDICINE, 2005, 7 (10): : 1356 - 1366
  • [8] THE ADENOVIRUS E1A-ASSOCIATED P300 PROTEIN IS DIFFERENTIALLY PHOSPHORYLATED IN AD12 E1A-COMPARED TO AD5 E1A-TRANSFORMED RAT-CELLS
    PEREIRA, DS
    JELINEK, T
    GRAHAM, FL
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 5 (06) : 1197 - 1205
  • [9] RECOMBINANT HUMAN ADENOVIRUSES CONTAINING HYBRID ADENOVIRUS TYPE-5 (AD5)/AD12 E1A GENES - CHARACTERIZATION OF HYBRID E1A PROTEINS AND ANALYSIS OF TRANSFORMING ACTIVITY AND HOST RANGE
    JELINEK, T
    GRAHAM, FL
    JOURNAL OF VIROLOGY, 1992, 66 (07) : 4117 - 4125
  • [10] Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA
    Elizabeth S. Gabitzsch
    Younong Xu
    Joseph P. Balint
    Zachary C. Hartman
    H. Kim Lyerly
    Frank R. Jones
    Cancer Immunology, Immunotherapy, 2010, 59 : 1131 - 1135